Posted in | News | Wind Power

EDP Renewables Signs a Build & Transfer Agreement for a 102 MW Wind Farm Project in the U.S.

EDP Renewables, a global leader in the renewable energy sector and one of the world’s largest wind energy producers, through its fully owned subsidiary EDP Renewables North America LLC, has signed a Build & Transfer Agreement with Northern Indiana Public Service Company LLC (“NIPSCO”).

The agreement enables the development and construction of EDPR’s 102 MW Rosewater Wind Farm in the U.S. state of Indiana, which is expected to come online by 2020, when the Build & Transfer Agreement would be completed.

With this new contract, EDPR has now secured 1.1 GW of wind energy agreements in the U.S. for projects to be installed in 2019 and 2020.

Completion of this transaction is subject to regulatory approval and other customary closing conditions for a transaction of this nature.

Source: https://www.edp.pt/particulares/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Energias de Portugal. (2019, February 05). EDP Renewables Signs a Build & Transfer Agreement for a 102 MW Wind Farm Project in the U.S.. AZoCleantech. Retrieved on April 20, 2024 from https://www.azocleantech.com/news.aspx?newsID=26027.

  • MLA

    Energias de Portugal. "EDP Renewables Signs a Build & Transfer Agreement for a 102 MW Wind Farm Project in the U.S.". AZoCleantech. 20 April 2024. <https://www.azocleantech.com/news.aspx?newsID=26027>.

  • Chicago

    Energias de Portugal. "EDP Renewables Signs a Build & Transfer Agreement for a 102 MW Wind Farm Project in the U.S.". AZoCleantech. https://www.azocleantech.com/news.aspx?newsID=26027. (accessed April 20, 2024).

  • Harvard

    Energias de Portugal. 2019. EDP Renewables Signs a Build & Transfer Agreement for a 102 MW Wind Farm Project in the U.S.. AZoCleantech, viewed 20 April 2024, https://www.azocleantech.com/news.aspx?newsID=26027.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.